SCHEMBL1781729

SCHEMBL1781729

[CH]1CCNCCNCCCN[CH]CN1

nearest known ligand 0.41

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL519615 0.88
SCHEMBL450284 0.77
SCHEMBL176488 0.75
SCHEMBL519086 0.72
SCHEMBL518397 0.69
Piperidine SCHEMBL28171392 0.68 ALDH1A1 (0.36)
SCHEMBL1783483 0.66 CXCR4 (0.60) CXCR4SMN1; SMN2
SCHEMBL1783486 0.66 CXCR4 (0.60) CXCR4SMN1; SMN2
SCHEMBL28143182 0.65
SCHEMBL576838 0.64 CXCR4 (1.00) CXCR4SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11332416-B2 Process for synthesizing fluorinated cyclic aliphatic compounds Westfälische Wilhelms-Universität Münster (DE) 2022-05-17 US disclosed
EP-3841060-A1 METHODS FOR THE DEGRADATION OF SF6 Westfälische Wilhelms-Universität Münster (DE) 2021-06-30 EP disclosed
EP-3601203-B1 PROCESS FOR SYNTHESIZING FLUORINATED CYCLIC ALIPHATIC COMPOUNDS UNIV MUENSTER WESTFAELISCHE WILHELMS (DE) 2021-04-07 EP disclosed
WO-2020200681-A1 POLYMERIZATION METHOD RHEINISCH-WESTFÄLISCHE TECHNISCHE HOCHSCHULE (RWTH) AACHEN (DE) 2020-10-08 WO disclosed
WO-2020058505-A1 ISOMERIZATION OF ALKENES RHEINISCH-WESTFÄLISCHE TECHNISCHE HOCHSCHULE (RWTH) AACHEN (DE) 2020-03-26 WO disclosed
US-10581001-B2 Organic electronic component having a charge carrier generation layer and the use of a zinc complex as a P-type dopant in charge carrier generation layers OSRAM OLED GMBH (DE) 2020-03-03 US disclosed
EP-3601203-A1 PROCESS FOR SYNTHESIZING FLUORINATED CYCLIC ALIPHATIC COMPOUNDS Westfälische Wilhelms-Universität Münster (DE) 2020-02-05 EP disclosed
US-10411197-B2 Main group metal complexes as P-dopants for organic electronic matrix materials SIEMENS AKTIENGESELLSCHAFT (DE) 2019-09-10 US disclosed
WO-2019162391-A1 METHOD FOR PRODUCING FLUORINATED HETEROCYCLIC ALIPHATIC COMPOUNDS Westfälische Wilhelms-Universität Münster (DE) 2019-08-29 WO disclosed
US-10305047-B2 Main group metal complexes as p-dopants for organic electronic matrix materials SIEMENS AKTIENGESELLSCHAFT (DE) 2019-05-28 US disclosed
WO-2001085717-A1 DIAZACYCLOALKANE DERIVATIVES AS BLEACH CATALYST AND COMPOSITION AND METHOD FOR BLEACHING A SUBSTRATE UNILEVER PLC (GB) 2001-11-15 WO disclosed
US-20010025019-A1 Bleaching composition UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. 2001-09-27 US disclosed
WO-2001064825-A1 BLEACHING COMPOSITION AND METHOD FOR BLEACHING LAUNDRY FABRICS UNILEVER PLC (GB) 2001-09-07 WO disclosed
WO-2001064828-A1 LAUNDRY BLEACHING AND DYE TRANSFER INHIBITING COMPOSITION UNILEVER PLC (GB) 2001-09-07 WO disclosed
WO-2001064824-A1 BLEACHING AND DYE TRANSFER INHIBITING COMPOSITION AND METHOD FOR STAIN BLEACHING OF LAUNDRY FABRICS UNILEVER PLC (GB) 2001-09-07 WO disclosed
WO-2001064994-A1 METHOD FOR REDUCING DYE FADING OF FABRICS IN LAUNDRY BLEACHING COMPOSITIONS UNILEVER PLC (GB) 2001-09-07 WO disclosed
US-20010009271-A1 Bleaching composition UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. 2001-07-26 US disclosed
WO-2001048138-A2 BLEACHING COMPOSITION UNILEVER N.V. (NL) 2001-07-05 WO disclosed
WO-2001048137-A1 BLEACHING COMPOSITION UNILEVER N.V. (NL) 2001-07-05 WO disclosed
WO-2001016272-A2 LIGAND AND COMPLEX FOR CATALYTICALLY BLEACHING A SUBSTRATE UNILEVER PLC (GB) 2001-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11332416-B2 Process for synthesizing fluorinated cyclic aliphatic compounds HRH4, HRH1, AHR CXCR4 1059/4885SMN1; SMN2 4460/4885
US-10581001-B2 Organic electronic component having a charge carrier generation layer and the use of a zinc complex as a P-type dopant in charge carrier generation layers SCO2, NCOA4, NR4A2 CXCR4 394/4885SMN1; SMN2 2217/4885
US-10305047-B2 Main group metal complexes as p-dopants for organic electronic matrix materials SCO2, SOD3, NCOA3 CXCR4 3361/4885SMN1; SMN2 1186/4885
US-10411197-B2 Main group metal complexes as P-dopants for organic electronic matrix materials SCO2, KMO, NOXO1 CXCR4 1914/4885SMN1; SMN2 1418/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.